U

United Laboratories International Holdings Ltd
HKEX:3933

Watchlist Manager
United Laboratories International Holdings Ltd
HKEX:3933
Watchlist
Price: 12.3 HKD 4.77% Market Closed
Market Cap: 22.3B HKD
Have any thoughts about
United Laboratories International Holdings Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
United Laboratories International Holdings Ltd

Wall Street analysts forecast United Laboratories International Holdings Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for United Laboratories International Holdings Ltd is 12.13 HKD with a low forecast of 10.35 HKD and a high forecast of 15.75 HKD.

Lowest
Price Target
10.35 HKD
16% Downside
Average
Price Target
12.13 HKD
1% Downside
Highest
Price Target
15.75 HKD
28% Upside
United Laboratories International Holdings Ltd Competitors:
Price Targets
SHE
Shedir Pharma Srl Unipersonale
67% Upside
4507
Shionogi & Co Ltd
14% Upside
HIKAL
Hikal Ltd
19% Upside
SECARE
Swedencare AB (publ)
26% Upside
4554
Fuji Pharma Co Ltd
45% Upside
ERIS
Eris Lifesciences Ltd
15% Upside
PFIZER
Pfizer Ltd
33% Upside
4506
Sumitomo Pharma Co Ltd
1% Downside

Revenue
Forecast

Revenue Estimate
United Laboratories International Holdings Ltd

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's revenue is 9%. The projected CAGR for the next 3 years is 6%.

9%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
United Laboratories International Holdings Ltd

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's operating income is 20%. The projected CAGR for the next 3 years is 4%.

20%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
United Laboratories International Holdings Ltd

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's net income is 52%. The projected CAGR for the next 3 years is 7%.

52%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is United Laboratories International Holdings Ltd's stock price target?
Price Target
12.13 HKD

According to Wall Street analysts, the average 1-year price target for United Laboratories International Holdings Ltd is 12.13 HKD with a low forecast of 10.35 HKD and a high forecast of 15.75 HKD.

What is United Laboratories International Holdings Ltd's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's revenue is 9%. The projected CAGR for the next 3 years is 6%.

What is United Laboratories International Holdings Ltd's Operating Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's operating income is 20%. The projected CAGR for the next 3 years is 4%.

What is United Laboratories International Holdings Ltd's Net Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's net income is 52%. The projected CAGR for the next 3 years is 7%.

Back to Top